Disitamab Vedotin: First Approval
This article summarizes the milestones in the development of disitamab vedotin leading to this first approval for locally advanced or metastatic gastric cancer.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Adenocarcinoma | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | China Health | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Lung Cancer | Non-Small Cell Lung Cancer